References

Chronic beryllium disease: update on a moving target

10.1016/j.chest.2020.07.074 · 2020 · External reference

Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant

10.1007/s004200100237 · 2001 · External reference

Efficacy of serial medical surveillance for chronic beryllium disease in a beryllium machining plant

10.1097/00043764-200103000-00011 · 2001 · External reference

The natural history of beryllium sensitization and chronic beryllium disease

10.1289/ehp.96104s5937 · 1996 · External reference

Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk

10.1164/rccm.200402-190oc · 2005 · External reference

Membrane complement regulatory proteins

10.1016/j.clim.2005.10.014 · 2006 · External reference

Distinct forms of DAF in urine and blood

10.1016/s0022-1759(01)00519-1 · 2002 · External reference

Bronchoalveolar lavage fluid protein expression in acute respiratory distress syndrome provides insights into pathways activated in subjects with different outcomes

10.1038/s41598-017-07791-8 · 2017 · External reference

Signal peptide for protein secretion directing glycophospholipid membrane anchor attachment

10.1126/science.2466338 · 1989 · External reference

Decay-accelerating factor modulates induction of T cell immunity

10.1084/jem.20041967 · 2005 · External reference

Complement regulators in extraocular muscle and experimental autoimmune myasthenia gravis

10.1016/j.expneurol.2004.06.005 · 2004 · External reference

Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protection

10.1172/jci16086 · 2002 · External reference

Deletion of decay-accelerating factor (CD55) exacerbates autoimmune disease development in MRL/lpr mice

10.1016/s0002-9440(10)64268-x · 2002 · External reference

Decay-accelerating factor deficiency increases susceptibility to dextran sulfate sodium-induced colitis: role for complement in inflammatory bowel disease

10.4049/jimmunol.172.6.3836 · 2004 · External reference

The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo

10.1084/jem.20040863 · 2005 · External reference

CD55 deposited on synovial collagen fibers protects from immune complex-mediated arthritis

10.1186/s13075-015-0518-4 · 2015 · External reference

Genomic biomarkers in chronic beryllium disease and sarcoidosis

10.1016/j.rmed.2021.106390 · 2021 · External reference

Novel protein pathways in development and progression of pulmonary sarcoidosis

10.1038/s41598-020-69281-8 · 2020 · External reference

The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF)

10.1084/jem.184.3.1185 · 1996 · External reference

Costimulation via CD55 on human CD4+ T cells mediated by CD97

10.4049/jimmunol.177.2.1070 · 2006 · External reference

Expression of the EGF-TM7 receptor CD97 and its ligand CD55 (DAF) in multiple sclerosis

10.1016/s0165-5728(02)00306-5 · 2002 · External reference

Expression of the activation antigen CD97 and its ligand CD55 in rheumatoid synovial tissue

10.1002/1529-0131(199904)42:4<650::aid-anr7>3.0.co;2-s · 1999 · External reference

Beryllium-induced lung disease exhibits expression profiles similar to sarcoidosis

10.1183/13993003.01469-2015 · 2016 · External reference

CD55 in cancer: complementing functions in a non-canonical manner

10.1016/j.canlet.2022.215935 · 2022 · External reference

An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease

10.1164/rccm.201409-1722st · 2014 · External reference

p38 mitogen–activated protein kinase in beryllium-induced dendritic cell activation

10.1016/j.humimm.2014.10.010 · 2014 · External reference

Identification of beryllium-dependent peptides recognized by CD4+ T cells in chronic beryllium disease

10.1084/jem.20122426 · 2013 · External reference

Mutagenesis of beryllium-specific TCRs suggests an unusual binding topology for antigen recognition

10.4049/jimmunol.1101872 · 2011 · External reference

Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease

10.1073/pnas.220430797 · 2000 · External reference

Decreased expression levels of complement regulator CD55 contribute to the development of bullous pemphigoid

10.18632/oncotarget.21216 · 2018 · External reference

Expression of CD55 and CD59 on peripheral blood cells from systemic lupus erythematosus (SLE) patients

10.1016/j.cellimm.2010.07.013 · 2010 · External reference

The changes of complement activities in sera of mice after subcutaneous administration of beryllium chloride [in Japanese]

10.1265/jjh.50.1077 · 1996 · External reference

A study of the humoral immunity of mice injected with beryllium chloride [in Japanese]

10.1265/jjh.47.934 · 1992 · External reference

The role of CD97 in regulating adaptive T-cell responses

10.1007/978-1-4419-7913-1_12 · 2010 · External reference

Deficient and dysfunctional regulatory T cells in the lungs of chronic beryllium disease subjects

10.1164/rccm.201001-0025oc · 2010 · External reference

Exploitation of the complement system by oncogenic Kaposi’s sarcoma–associated herpesvirus for cell survival and persistent infection

10.1371/journal.ppat.1004412 · 2014 · External reference